Export 1889 results:
Author [ Title(Desc)] Type Year
Filters: First Letter Of Last Name is M  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
Gonçalves, A. P., Videira, A., Máximo, V., & Soares, P. (2011). Synergistic growth inhibition of cancer cells harboring the RET/PTC1 oncogene by staurosporine and rotenone involves enhanced cell death. Journal of Biosciences, 36(4), 639 - 648.
Cardoso, I., Martins, D., Ribeiro, T., Merlini, G., & Saraiva, M. J. (2010). Synergy of combined Doxycycline/TUDCA treatment in lowering Transthyretin deposition and associated biomarkers: Studies in FAP mouse models. Journal of Translational Medicine, 8.
Cardoso, I., Martins, D., Ribeiro, T., Merlini, G., & Saraiva, M. J. (2010). Synergy of combined Doxycycline/TUDCA treatment in lowering Transthyretin deposition and associated biomarkers: Studies in FAP mouse models. Journal of Translational Medicine, 8.
Oliveira, J., Ralton, L., Tavares, J., Codeiro-da-Silva, A., et al. (2007). The synthesis and the in vitro cytotoxicity studies of bisnaphthalimidopropyl polyamine derivatives against colon cancer cells and parasite Leishmania infantum. Bioorganic and Medicinal Chemistry, 15(1), 541 - 545.
Cunha, C., Almeida, C. R., Almeida, M. I., Silva, A. M., et al. (2017). Systemic delivery of bone marrow mesenchymal stem cells for in situ intervertebral disc regeneration. Stem Cells Translational Medicine, 6(3), 1029 - 1039.
Cunha, C., Almeida, C. R., Almeida, M. I., Silva, A. M., et al. (2017). Systemic delivery of bone marrow mesenchymal stem cells for in situ intervertebral disc regeneration. Stem Cells Translational Medicine, 6(3), 1029 - 1039.
Miranda, C. O., Teixeira, C. A., Liz, M. A., Sousa, V. F., et al. (2011). Systemic delivery of bone marrow-derived mesenchymal stromal cells diminishes neuropathology in a mouse model of Krabbe's disease. Stem Cells, 29(11), 1738 - 1751.
T
da VG, G., de M, M. A., A, M. S., R, L., et al. (2014). T Cell Activation Regulates CD6 Alternative Splicing by Transcription Dynamics and SRSF1. J Immunol, 193(1).
da VG, G., de M, M. A., A, M. S., R, L., et al. (2014). T Cell Activation Regulates CD6 Alternative Splicing by Transcription Dynamics and SRSF1. J Immunol, 193(1).
da Glória, V. G., Martins de Araújo, M., Mafalda Santos, A., Leal, R., et al. (2014). T Cell Activation Regulates CD6 Alternative Splicing by Transcription Dynamics and SRSF1. J Immunol, 193(1).
da Glória, V. G., Martins de Araújo, M., Mafalda Santos, A., Leal, R., et al. (2014). T Cell Activation Regulates CD6 Alternative Splicing by Transcription Dynamics and SRSF1. J Immunol, 193(1).
da Glória, V. G., Martins de Araújo, M., Mafalda Santos, A., Leal, R., et al. (2014). T Cell Activation Regulates CD6 Alternative Splicing by Transcription Dynamics and SRSF1. J Immunol, 193(1).
James, J. R., McColl, J., Oliveira, M. I., Dunne, P. D., et al. (2011). The T cell receptor triggering apparatus is composed of monovalent or monomeric proteins. Journal of Biological Chemistry, 286(37), 31993 - 32001.
James, J. R., McColl, J., Oliveira, M. I., Dunne, P. D., et al. (2011). The T cell receptor triggering apparatus is composed of monovalent or monomeric proteins. Journal of Biological Chemistry, 286(37), 31993 - 32001.
James, J. R., McColl, J., Oliveira, M. I., Dunne, P. D., et al. (2011). The T cell receptor triggering apparatus is composed of monovalent or monomeric proteins. Journal of Biological Chemistry, 286(37), 31993 - 32001.
Lee, J. - H., Lee, J. - M., Ramos, E. M., Gillis, T., et al. (2012). TAA repeat variation in the GRIK2 gene does not influence age at onset in Huntington's disease. Biochemical and Biophysical Research Communications, 424(3), 404 - 408.
Lee, J. - H., Lee, J. - M., Ramos, E. M., Gillis, T., et al. (2012). TAA repeat variation in the GRIK2 gene does not influence age at onset in Huntington's disease. Biochemical and Biophysical Research Communications, 424(3), 404 - 408.
Lee, J. - H., Lee, J. - M., Ramos, E. M., Gillis, T., et al. (2012). TAA repeat variation in the GRIK2 gene does not influence age at onset in Huntington's disease. Biochemical and Biophysical Research Communications, 424(3), 404 - 408.
Lee, J. - H., Lee, J. - M., Ramos, E. M., Gillis, T., et al. (2012). TAA repeat variation in the GRIK2 gene does not influence age at onset in Huntington's disease. Biochemical and Biophysical Research Communications, 424(3), 404 - 408.
Lee, J. - H., Lee, J. - M., Ramos, E. M., Gillis, T., et al. (2012). TAA repeat variation in the GRIK2 gene does not influence age at onset in Huntington's disease. Biochemical and Biophysical Research Communications, 424(3), 404 - 408.
Lee, J. - H., Lee, J. - M., Ramos, E. M., Gillis, T., et al. (2012). TAA repeat variation in the GRIK2 gene does not influence age at onset in Huntington's disease. Biochemical and Biophysical Research Communications, 424(3), 404 - 408.
Lee, J. - H., Lee, J. - M., Ramos, E. M., Gillis, T., et al. (2012). TAA repeat variation in the GRIK2 gene does not influence age at onset in Huntington's disease. Biochemical and Biophysical Research Communications, 424(3), 404 - 408.
Scarff, C. A., Sicorello, A., Tomé, R. J. L., Macedo-Ribeiro, S., et al. (2012). A tale of a tail: Structural insights into the conformational properties of the polyglutamine protein ataxin-3. International Journal of Mass Spectrometry.
Scarff, C. A., Sicorello, A., Tomé, R. J. L., Macedo-Ribeiro, S., et al. (2013). A tale of a tail: Structural insights into the conformational properties of the polyglutamine protein ataxin-3. International Journal of Mass Spectrometry, 345-347, 63 - 70.
Vergnes, B., Sereno, D., Tavares, J., Cordeiro-da-Silva, A., et al. (2005). Targeted disruption of cytosolic SIR2 deacetylase discloses its essential role in Leishmania survival and proliferation. Gene, 363(1-2), 85 - 96.

Pages


Home | Site Map | Contacts | Credits | Privacy & Cookies | Intranet | Social Networks |


rua alfredo allen, 208, 4200-135 porto - portugal | tel +351 220 408 800 | email: info@i3s.up.pt | © copyright 2010 ibmc